AdipoLABs (CEO Han Sung-ho) is participating in the 34th International Medical & Hospital Equipment Show (KIMES 2018) held at COEX from March 15th (Thu) to 18th (Sun). AdipoLABs will display 'REMISSION 1℃', a high-frequency hyperthermia medical device that has been approved for manufacturing on October 23rd, 2015 by Korean FDA.

'REMISSION 1℃' is a hyperthermia high-frequency medical device developed with pure Korean technology. It treats cancers by applying strong high frequency of 0.46MHz to the human body and generate magnificent deep heat above 40 ℃ from inside.

Case studies demonstrated that with the use of REMISSION 1 ℃, side effects of chemotherapy and immunotherapy were reduced and the result of treatment was ameliorated. In December 2017, the journal of Korean Society for Thermal Medicine (KSTM) showed a case of improvement in pancreatic cancer and breast cancer. REMISSION 1°C is currently used as a hyperthermia high-frequency medical equipment for cancer at the hospitals of universities, cancer nursing homes and local hospitals.

AdipoLABs is a company that has developed REMISSION 1℃ based on the data that have been accumulated for making high frequency obesity treatment and pain relief devices. It is a medical device manufacturing company that has developed many sorts of high frequency medical devices.

Meanwhile, KIMES 2018 is Korea's largest medical and hospital equipment exhibition displaying ubiquitous healthcare, environmentally-conscious medical waste facility, high-tech hospital facility built with beautiful building-technology, medical information system combined with IT technology for prompt patient-care. The medical industry, including the automotive industry for transportation, is introducing new technologies and new products that have been fused with all industries.